Mass Screening
22
1
2
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 22 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (22)
SMS Messaging as a Tool to Improve Cancer Screening Programs
Using Consumer-grade Wearable Devices for Fall Risk Evaluation and Alerts
Preventing Early-Onset Colorectal Cancer in the VA
Remote Breast Cancer Screening Study
The Intersectional Viborg Screening Program: Cost-(Effectiveness) of Screening for Diabetes and Cardiovascular Diseases
Three Birds With One Stone
Smart Phone App for COLOnoscopic PREParation
imPulse™ Una Infrasound-to-ultrasound E-stethoscope
Sensitivity of Fecal Immunochemical Test (FIT) for Colorectal Cancer (CRC) Screening
Fecal Metagenomics and Metabolomics Analyses to Identify Potential Screening Biomarkers for Colorectal Polyps and Cancer in Chinese Population
Quality of Life of Colorectal Cancer Screenees in the Period Between Colonoscopy and Next Clinic Visit for Final Report: Does Real-time Endoscopic Optical Diagnosis Improve Their Quality of Life
Effect of Incidental Findings Information on Lung Cancer Screening Intent
Offering Cervical Cancer Screening to Older Women
Effectiveness of a Web-based Intervention to Promote Health Screening in Men
Methods of Computed Tomography Screening and Management of Lung Cancer
Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai, China
Usability Study of a Self-test Prototype for Human Immunodeficiency Virus (HIV) Screening
Stepwise Strategy to Improve CANcer Screening Adherence: Cervical Cancer
RCT of Mailed Brochure to Boost Adherence to Screening Colonoscopy
Survey of ColoRectal Cancer Education and Environment Needs